Dalrada Financial CORP Stock: price and insider trades · United States · SEC (Form 4)Track the Dalrada Financial CORP share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Banks sector, Dalrada Financial CORP has logged 59 insider filings. The latest transaction was disclosed on 6 February 2025 (Acquisition). Among the most active insiders: BONAR BRIAN. All data is free.
€107,217
44 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 February 2025
All Executives59 Thresholds0 Prospectus0 Other0
Declarations 59 total
▲ Chief Executive Officer · Executives · 6 Jan 2025
20,000 shares @ US$0.0592 1.5% of flow Common Stock Par Value $.005 SEC:0001683168-25-000786:0
Canonical exit: 6 Apr 2025 (T+90) ▲ Chief Executive Officer · Executives · 2 Dec 2024
1,300 shares @ US$0.0306 0.0% of flow Common Stock Par Value $.005 SEC:0001683168-25-000348:0
Canonical exit: 2 Mar 2025 (T+90) ▲ Chief Executive Officer · Executives · 19 Dec 2024
300 shares @ US$0.0645 0.0% of flow Common Stock Par Value $.005 SEC:0001683168-25-000348:1
Canonical exit: 19 Mar 2025 (T+90) ▲ Chief Executive Officer · Executives · 26 Dec 2024
15,000 shares @ US$0.0597 1.1% of flow Common Stock Par Value $.005 SEC:0001683168-25-000348:2
Canonical exit: 26 Mar 2025 (T+90) ▲ Chief Executive Officer · Executives · 6 Nov 2024
1,000 shares @ US$0.0849 0.1% of flow Common Stock Par Value $.005 SEC:0001683168-24-008786:0
Canonical exit: 4 Feb 2025 (T+90) ▲ Chief Executive Officer · Executives · 12 Aug 2024
10,000 shares @ US$0.175 2.0% of flow Common Stock Par Value $.005 SEC:0001683168-24-007455:0
Canonical exit: 10 Nov 2024 (T+90) ▲ Chief Executive Officer · Executives · 29 Aug 2024
17,977 shares @ US$0.1609 3.3% of flow Common Stock Par Value $.005 SEC:0001683168-24-007455:1
Canonical exit: 27 Nov 2024 (T+90) ▲ Chief Executive Officer · Executives · 3 Sept 2024
5,000 shares @ US$0.1552 0.9% of flow Common Stock Par Value $.005 SEC:0001683168-24-007455:2
Canonical exit: 2 Dec 2024 (T+90) ▲ Chief Executive Officer · Executives · 23 Sept 2024
10,000 shares @ US$0.13 1.5% of flow Common Stock Par Value $.005 SEC:0001683168-24-007455:3
Canonical exit: 22 Dec 2024 (T+90) ▲ Chief Executive Officer · Executives · 11 Oct 2024
20,000 shares @ US$0.0989 2.3% of flow Common Stock Par Value $.005 SEC:0001683168-24-007455:4
Canonical exit: 9 Jan 2025 (T+90) ▲ Chief Executive Officer · Executives · 3 Jul 2024
1,000 shares @ US$0.19 0.2% of flow Common Stock Par Value $.005 SEC:0001683168-24-005337:0
Canonical exit: 1 Oct 2024 (T+90) ▲ Chief Executive Officer · Executives · 3 Apr 2024
8,920 shares @ US$0.1519 1.6% of flow Common Stock Par Value $.005 SEC:0001683168-24-004981:0
Canonical exit: 2 Jul 2024 (T+90) ▲ Chief Executive Officer · Executives · 5 Feb 2024
8,500 shares @ US$0.1596 1.6% of flow Common Stock Par Value $.005 SEC:0001683168-24-002163:0
Canonical exit: 5 May 2024 (T+90) ▲ Chief Executive Officer · Executives · 5 Jan 2024
24,000 shares @ US$0.1827 5.1% of flow Common Stock Par Value $.005 SEC:0001683168-24-001061:0
Canonical exit: 4 Apr 2024 (T+90) ▲ Chief Executive Officer · Executives · 30 Nov 2023
20,000 shares @ US$0.1911 4.4% of flow Common Stock Par Value $.005 SEC:0001683168-24-000790:0
Canonical exit: 28 Feb 2024 (T+90) ▲ Chief Executive Officer · Executives · 16 Nov 2023
9,000 shares @ US$0.2907 3.0% of flow Common Stock Par Value $.005 SEC:0001683168-23-008949:0
Canonical exit: 14 Feb 2024 (T+90) ▲ Chief Executive Officer · Executives · 6 Sept 2023
4,000 shares @ US$0.2453 1.2% of flow Common Stock Par Value $.005 SEC:0001683168-23-007105:0
Canonical exit: 5 Dec 2023 (T+90) ▲ Chief Executive Officer · Executives · 28 Aug 2023
3,000 shares @ US$0.193 0.9% of flow Common Stock, Par Value $.005 SEC:0001683168-23-006644:0
Canonical exit: 26 Nov 2023 (T+90) ▲ Chief Executive Officer · Executives · 27 Jul 2023
15,000 shares @ US$0.149 2.6% of flow Common Stock, Par Value $.005 SEC:0001683168-23-005408:0
Canonical exit: 25 Oct 2023 (T+90) ▲ Chief Executive Officer · Executives · 1 Jun 2023
36,500 shares @ US$0.1167 5.0% of flow Common Stock, Par Value $.005 SEC:0001683168-23-004830:0
Canonical exit: 30 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 6 May 2023
100 shares @ US$0.1085 0.0% of flow Common Stock, Par Value $.005 SEC:0001683168-23-003958:0
Canonical exit: 4 Aug 2023 (T+90) ▲ Chief Executive Officer · Executives · 3 Apr 2023
20,800 shares @ US$0.0998 2.4% of flow Common Stock, Par Value $.005 SEC:0001683168-23-002942:0
Canonical exit: 2 Jul 2023 (T+90) ▲ Chief Executive Officer · Executives · 7 Feb 2023
10,500 shares @ US$0.1543 1.9% of flow Common Stock, par value $.005 SEC:0001683168-23-002771:0
Canonical exit: 8 May 2023 (T+90) ▲ Chief Executive Officer · Executives · 7 Nov 2022
30,000 shares @ US$0.1389 5.3% of flow Common Stock, Par Value $.005 SEC:0001683168-23-000285:0
Canonical exit: 5 Feb 2023 (T+90) ▲ Chief Executive Officer · Executives · 29 Sept 2022
6,850 shares @ US$0.1078 0.9% of flow Common Stock, Par Value $.005 SEC:0001683168-22-007833:0
Canonical exit: 28 Dec 2022 (T+90) 25 of 59 declarations
Load more (34 remaining) 关于 Dalrada Financial CORP Dalrada Financial Corporation(股票代码 DFCO)是一家美国上市公司,其最新的备案文件和投资者材料表明其为 OTC 交易状态,而非所审查来源中活跃的 NYSE/NASDAQ 上市公司。对于投资者而言,该公司最好被理解为一家多元化的运营控股公司,尽管其公司名称听起来像金融公司,但其业务涵盖工业、技术、医疗保健和清洁能源主题。Dalrada 最初于1982年9月在加利福尼亚州注册成立,后在特拉华州重新注册,并于2020年5月5日在怀俄明州重新注册。其主要行政办公室位于加利福尼亚州埃斯孔迪多,其备案文件和公司通讯描述了其在美国和国际上更广泛的运营足迹。([sec.gov](https://www.sec.gov/Archives/edgar/data/725394/000168316822001440/dalrada_s1.htm?utm_source=openai))
该集团目前围绕五个部门组织其业务:Genefic、Dalrada Climate Technology、Dalrada Precision Manufacturing、Dalrada Technologies 和 Dalrada Corporate。Genefic 专注于医疗保健相关解决方案,包括诊断、药品和健康服务。Dalrada Climate Technology 专注于脱碳和能源效率产品,包括热泵和相关的气候解决方案。Dalrada Precision Manufacturing 发展精密制造能力,而 Dalrada Technologies 则提供 IT 和先进技术产品。实际上,这使得 Dalrada 成为一个多垂直平台,而非单一业务运营公司。([sec.gov](https://www.sec.gov/Archives/edgar/data/0000725394/000168316825007318/dalrada_i10k-063025.htm?utm_source=openai))
从竞争角度来看,Dalrada 在专业利基市场中运营,其中执行、产品商业化以及扩展工程解决方案的能力至关重要。公司最近的通讯强调了核心终端市场,例如清洁能源、高效供暖和制冷系统、大气水生成以及半导体薄膜沉积。2024年11月,该公司宣布在俄勒冈州波特兰为 Deposition Technology USA 建立新的制造和研发设施,称其为新的美国总部,并以此支持北美日益增长的需求。此举表明其致力于加强国内工业基础并深化其在先进制造领域的存在。([dalrada.com](https://dalrada.com/dalrada-establishes-deposition-technology-usa-presence-with-new-portland-facility/?utm_source=openai))
与此同时,截至2025年6月30日的最新 SEC 年度报告强调了重大的财务风险。该文件指出,公司遭受了持续的运营亏损,并且存在净资本不足,这对其持续经营能力提出了重大疑问。Dalrada 在 SEC 备案文件中提及的2026年1月致股东信中表示,公司在可再生能源/热泵产品、大气水生成器和半导体沉积解决方案方面取得了运营进展,同时还强调了合作、安装和重组工作。然而,所审查的来源没有提供足够的审计证据来确认持久的财务好转。总的来说,DFCO 仍然是一个高风险、事件驱动的股权故事,与工业转型相关,但存在重大的资产负债表和执行风险。([sec.gov](https://www.sec.gov/Archives/edgar/data/725394/000168316825007318/dalrada_i10k-063025.htm)